1,131 results on '"Kullberg, Bart-Jan"'
Search Results
152. Sepsis - Theory and Therapies
153. Regulation of Staphylococcus epidermidis-induced IFN-γ in whole human blood: the role of endogenous IL-18, IL-12, IL-1, and TNF
154. Cytokine Release in Healthy Donors and Patients with Chronic Granulomatous Disease upon Stimulation with Aspergillus fumigatus
155. Delayed clearance of intraabdominal abscesses caused by Candida albicans in tumor necrosis factor-[alpha] and lymphotoxin-[alpha]-deficient mice
156. The role of endogenous interleukin (IL)-18, IL-12, IL-1[beta], and tumor necrosis factor-[alpha] in the production of interferon-[gamma] induced by Candida albicans in human whole-blood cultures
157. Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients
158. Interleukin-1 and related pro-inflammatory cytokines in the treatment of bacterial infections in neutropenic and non-neutropenic animals
159. Cytokines in the treatment of fungal infections
160. Quality Indicators for Appropriate Outpatient Parenteral Antimicrobial Therapy in Adults: A Systematic Review and RAND-modified Delphi Procedure
161. Prophylactic antibiotics reduce hospitalisations and cost in locally advanced head and neck cancer patients treated with chemoradiotherapy: A randomised phase 2 study
162. A Genome-Wide Functional Genomics Approach Identifies Susceptibility Pathways to Fungal Bloodstream Infection in Humans
163. Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect)
164. 18F-FDG PET/CT–Guided Treatment Duration in Patients with High-Risk Staphylococcus Aureus Bacteremia: A Proof of Principle
165. Quality of outpatient parenteral antimicrobial therapy (OPAT) care from the patient’s perspective: a qualitative study
166. Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial
167. Proinflammatory Cytokines and Treatment of Disease
168. Deeply invasive candidiasis
169. Does the shape of lipid A determine the interaction of LPS with Toll-like receptors?
170. Low-Density Lipoprotein Receptor-deficient Mice Are Protected Against Lethal Endotoxemia and Severe Gram-negative Infections
171. Reply to Kontoyiannis
172. Antibiotic research and development: business as usual?
173. still a concern in patients with haematological malignancies and stem cell transplant recipients-authors' response
174. Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients-authors' response
175. Purpura fulminans and symmetrical peripheral gangrene caused by Capnocytophaga canimorsus (formerly DF-2) septicemia - a complication of dog bite
176. Immunologic defects in severe mucocutaneous HSV-2 infections: Response to IFN-γ therapy
177. Quality Indicators for Appropriate Outpatient Parenteral Antimicrobial Therapy in Adults: A Systematic Review and RAND-modified Delphi Procedure.
178. Cost-effectiveness of longer-term versus shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease
179. Neutrophils differentially attenuate immune response toAspergillusinfection through complement receptor 3 and induction of myeloperoxidase
180. Therapy of invasive fungal infections
181. Pharmacologic Inhibitors of Tumor Necrosis Factor Production Exert Differential Effects in Lethal Endotoxemia and in Infection with Live Microorganisms in Mice
182. Phospholipase A2 Is a Circulating Mediator in Typhoid Fever
183. Recombinant Interferon-γ Enhances Resistance to Acute Disseminated Candida Albicans Infection in Mice
184. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients
185. ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients
186. AIDS-related mycoses: the way forward
187. Introduction: Cytokines in the biotherapy of infectious diseases
188. Influenza-associated Aspergillosis in Critically Ill Patients
189. Monitoring, documenting and reporting the quality of antibiotic use in the Netherlands: a pilot study to establish a national antimicrobial stewardship registry
190. An electronic trigger tool to optimise intravenous to oral antibiotic switch: a controlled, interrupted time series study
191. An integrative genomics approach identifies novel pathways that influence candidaemia susceptibility
192. Adjuvant interferon-gamma immunotherapy in a patient with progressive cerebral Nocardia abscesses
193. Cost-effectiveness of prophylactic antibiotics to prevent pneumonia in patients treated with chemoradiotherapy (CRT) for locally advanced head and neck carcinoma (LAHNC).
194. Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study
195. Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials
196. 18F-FDG PET/CT Optimizes Treatment in Staphylococcus Aureus Bacteremia and Is Associated with Reduced Mortality
197. Functional and Genomic Architecture of Borrelia burgdorferi -Induced Cytokine Responses in Humans
198. 18F-FDG PET/CT-Guided Treatment Duration in Patients with High-Risk Staphylococcus Aureus Bacteremia: A Proof of Principle.
199. Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.
200. The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.